Gonococcal Infection clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection
Sorry, in progress, not accepting new patients
This is a Phase II, randomized, observer-blind, placebo-controlled, multi-site trial of the FDA licensed rMenB+OMV NZ vaccine, Bexsero. The targeted study population is men and women 18-50 years of age who are disproportionately vulnerable to N.…
at UCLA
Last updated: